US FDA Finds Negligible Cancer Risks In Metformin Products
The US FDA finds metformin meets NDMA impurity threshold and urges diabetics to continue taking it.
The US FDA finds metformin meets NDMA impurity threshold and urges diabetics to continue taking it.